Premium
Letter: oral low‐dose methotrexate for collagenous colitis – authors’ reply
Author(s) -
FernándezBañares F.,
Gisbert J. P.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13661
Subject(s) - collagenous colitis , microscopic colitis , medicine , budesonide , methotrexate , colitis , placebo , gastroenterology , clinical trial , adverse effect , drug , refractory (planetary science) , first line , disease , inflammatory bowel disease , pathology , pharmacology , corticosteroid , alternative medicine , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom